drugset / Trial / NCT02687373

Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in Kenya

NCT02687373

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study will be conducted in Siaya County in Nyanza Province, western Kenya. Healthy children aged 5 months through 9 years of age living within approximately 10 km of the study clinic(s) (Siaya County Referral Hospital, or Wagai dispensary, a government health facility in Wagai division) will be eligible for participation in Part 1; healthy infants aged 5 months - 12 months inclusive will be eligible for Part 2.

Timeline

Start
2016-07-21
Primary completion
2018-08
Completion
2018-08-14

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PfSPZ Vaccine Vaccine 135000 unknown Intravenous
Subject PfSPZ Vaccine Vaccine 270000 unknown Intravenous
Subject PfSPZ Vaccine Vaccine 450000 unknown Intravenous
Subject PfSPZ Vaccine Vaccine 900000 unknown Intravenous
Subject PfSPZ Vaccine Vaccine 1.8e+06 unknown Intravenous

Indications